January, 2017 | The Wall Street Analyzer

Latest News

[ July 9, 2025 ] Soligenix Corporate Update Letter – Key Highlights and Upcoming Milestones News Feed
[ July 2, 2025 ] Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier News Feed
[ June 20, 2025 ] Canadian Gold Corp. Private Placement Offering for New Hammond Reef South Program to Follow up 2024 Surface Samples That Returned 35.4 g/t Gold Market News
[ June 20, 2025 ] HNO International Leads Groundbreaking Collaboration to Transform Toxic Fracking Water Into Clean Hydrogen for up to $5M in Annual Hydrogen Sales News Feed
[ June 11, 2025 ] Canadian Gold Corp. Intersects Two Separate High-Grade Zones Returning 12.9 gpt Gold Over 3.0 Metres & 7.6 gpt Over 5.8 Metres Within Broad Mineralized Intervals at South Zone News Feed
[ June 4, 2025 ] Pasofino Gold Engages MineScope Services to Conduct Phase One Feasibility Study Update at Dugbe Gold Project News Feed
[ May 13, 2025 ] Canadian Gold Corp. Tartan South Zone Continues to Hit: 140m Vertical Expansion Intersects 9.4 gpt Gold/ 3.3m News Feed

No Picture

Gevo, Inc (NASDAQ: GEVO) CEO Interview

January 26, 2017 The Wall Street Analyzer Comments Off

Interview with Patrick Gruber, CEO […]

No Picture

Lexaria Bioscience (OTCQB:LXRP) (CSE:LXX) CEO Interview

January 25, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Chris Bunka […]

No Picture

Park Place Energy (OTCQB: PKPL) CEO Interview

January 25, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Scott Larsen […]

No Picture

Tamarack Valley Energy Ltd. (TSX: TVE) CEO Interview

January 24, 2017 The Wall Street Analyzer Comments Off

Interview with Brian Schmidt, CEO […]

No Picture

Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) CEO Interview

January 24, 2017 The Wall Street Analyzer Comments Off

Interview with Marc Voight, CEO […]

No Picture

Aphria, Inc. (TSXV: APH) (OTCQB: APHQF) Management Interview

January 19, 2017 The Wall Street Analyzer Comments Off

Interview with Carl Merton, CFO […]

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) CEO Interview Update

January 18, 2017 The Wall Street Analyzer Comments Off

Interview update with Jeffrey Bacha, CEO […]

No Picture

AudioEye, Inc. (OTCQB: AEYE) CEO INTERVIEW

January 12, 2017 The Wall Street Analyzer Comments Off

Interview with Todd Bankofier, CEO […]

ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) CEO Interview

January 9, 2017 The Wall Street Analyzer 1

Interview update with CEO James Sapirstein […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com